{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:26:40Z","timestamp":1773260800682,"version":"3.50.1"},"reference-count":63,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1995,9]]},"DOI":"10.1136\/gut.37.3.301","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"301-304","source":"Crossref","is-referenced-by-count":22,"title":["The ursodeoxycholic acid story in primary biliary cirrhosis."],"prefix":"10.1136","volume":"37","author":[{"given":"A G","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R P","family":"Jazrawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T C","family":"Northfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1995,9,1]]},"reference":[{"key":"ref_1","first-page":"43","article-title":"Hepatoprotective effect of ursodeoxycholate in experimental animals","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Kitani, K.","year":"1990","unstructured":"Kitani K. Hepatoprotective effect of ursodeoxycholate in experimental animals. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic Publishers, 1990: 43-56."},{"key":"ref_2","first-page":"11","article-title":"Naturally occurring bile acids and alcohols and their origins","volume-title":"The bile acids","author":"Matschiner, J.T.","year":"1971","unstructured":"Matschiner JT. Naturally occurring bile acids and alcohols and their origins. In: Kritchevsky D, Nair PP, eds. The bile acids. New York: Plenum Press, 1971: 11-46."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two year follow up: a pilot study","volume":"30","author":"Leuschner, U.; Leuschner, M.; Sieratzki, J.; Kurtz, W.; Hubner, K.","year":"1985","unstructured":"Leuschner U, Leuschner M, Sieratzki J, Kurtz W, Hubner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two year follow up: a pilot study. DigDis Sci 1985; 30: 642-9.","journal-title":"DigDis Sci"},{"key":"ref_4","first-page":"1061","article-title":"Ursodeoxycholic acid in chronic liver disease","volume":"31","author":"JS, De Caestecker; RP, Jazrawi; ML, Petroni; TC, Northfield","year":"1991","unstructured":"De Caestecker JS, Jazrawi RP, Petroni ML, Northfield TC. Ursodeoxycholic acid in chronic liver disease. Gut 1991; 31: 1061-5.","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(87)92421-4","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","volume":"ii:","author":"Hafmann, A.F.; Popper, H.","year":"1987","unstructured":"Hafmann AF, Popper H. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 1987; ii: 398-9.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and class II histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus, Y.; Gane, P.; Rouger, P.; Poupon, R.","year":"1990","unstructured":"Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-5.","journal-title":"Hepatology"},{"key":"ref_7","first-page":"1194","article-title":"Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy","volume":"86","author":"Terasaki, S.; Nakanuma, Y.; Ogino, H.; Unoura, M.; Kobayashi, K.","year":"1991","unstructured":"Terasaki S, Nakanuma Y, Ogino H, Unoura M, Kobayashi K. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. Am Jf Gastroenterol 1991; 86: 1194-9.","journal-title":"Am Jf Gastroenterol"},{"key":"ref_8","first-page":"1371","article-title":"Cholestasis induces major histocompatibility complex class I","volume-title":"expression in hepatocytes. Gastroenterology 1992; 102","author":"Calmus, Y.; Arvieux, C.; Gane, P.; Boucher, E.; Nordlinger, B.; Rouger, P.; Poupon, R.","unstructured":"Calmus Y, Arvieux C, Gane P, Boucher E, Nordlinger B, Rouger P, Poupon R. Cholestasis induces major histocompatibility complex class I expression in hepatocytes. Gastroenterology 1992; 102: 1371-7."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"and the UDCA study group. A multicenter double blind trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon, R.E.; Balkau, B.; Eschwege, E.; Poupon, R.","year":"1991","unstructured":"Poupon RE, Balkau B, Eschwege E, Poupon R, and the UDCA study group. A multicenter double blind trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl_t Med 1991; 324: 1548-54.","journal-title":"N Engl_t Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor, K.D.; Dickson, E.R.; Baldus, W.P.; Jorgensen, R.A.; Ludwig, J.; Murtagh, P.A.","year":"1994","unstructured":"Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtagh PA, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106: 1284-94.","journal-title":"Gastroenterology"},{"key":"ref_11","first-page":"193","article-title":"Effect of ursodeoxycholic acid treatment on interferon-g synthesis in patients with primary biliary cirrhosis","volume":"16","author":"Ogino, H.; Unoura, M.; Saeki, R.; Terasaki, S.; Kawai, H.; Matushita, E.","year":"1992","unstructured":"Ogino H, Unoura M, Saeki R, Terasaki S, Kawai H, Matushita E, et al. Effect of ursodeoxycholic acid treatment on interferon-g synthesis in patients with primary biliary cirrhosis. Hepatology 1992; 16: 193A.","journal-title":"Hepatology"},{"key":"ref_12","first-page":"373","article-title":"Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis","volume-title":"I Hepatol","volume":"18","author":"Kurktschiev, D.; Subat, S.; Adler, D.; Schentke, K.-U.","year":"1993","unstructured":"Kurktschiev D, Subat S, Adler D, Schentke K-U. Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. I Hepatol 1993; 18: 373-7."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa, M.; Tsujii, T.; Matsumara, K.; Yamao, J.; Matsumura, Y.; Kubo, R.","year":"1992","unstructured":"Yoshikawa M, Tsujii T, Matsumara K, Yamao J, Matsumura Y, Kubo R, et al. Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology 1992; 16: 358-64.","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hep.1840180125","article-title":"The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells","volume":"18","author":"Lacaille, F.; Paradis, K.","year":"1993","unstructured":"Lacaille F, Paradis K. The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 1993; 18: 165-72.","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/hep.1840160317","article-title":"Differential effects of chenodeoxycholic acid and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumour necrosis factor-a production by monocytes","volume":"16","author":"Calmus, Y.; Guechot, J.; Podevin, P.; Bonnefis, M.-T.; Giboudeau, J.; Poupon, R.","year":"1992","unstructured":"Calmus Y, Guechot J, Podevin P, Bonnefis M-T, Giboudeau J, Poupon R. Differential effects of chenodeoxycholic acid and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumour necrosis factor-a production by monocytes. Hepatology 1992; 16: 719-23.","journal-title":"Hepatology"},{"key":"ref_16","first-page":"617","article-title":"Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids","volume-title":"the mouse. Gastroenterology 1992; 103","author":"Calmus, Y.; Weill, B.; Ozier, Y.; Chereau, C.; Houssin, D.; Poupon, R.","unstructured":"Calmus Y, Weill B, Ozier Y, Chereau C, Houssin D, Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 1992; 103: 617-21."},{"key":"ref_17","first-page":"407","article-title":"Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat","volume":"248","author":"Kitani, K.; Ohta, M.; Kanai, S.","year":"1985","unstructured":"Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. Am J Physiol 1985; 248: G407-8.","journal-title":"Am J Physiol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0016-5085(80)90078-5","article-title":"Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport","volume":"79","author":"Dumont, M.; Erlinger, S.; Uchman, S.","year":"1980","unstructured":"Dumont M, Erlinger S, Uchman S. Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology 1980; 79: 82-9.","journal-title":"Gastroenterology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/hep.1840110527","article-title":"Hypercholoretic bile acids: a clue to the mechanism?","volume":"11","author":"Erlinger, S.","year":"1990","unstructured":"Erlinger S. Hypercholoretic bile acids: a clue to the mechanism? Hepatology 1990; 11: 888-90.","journal-title":"Hepatology"},{"key":"ref_20","first-page":"134","article-title":"Kinetics of hepatic handling in cholestatic liver disease: effect","volume-title":"of ursodeoxycholic acid. Gastroenterology","volume":"106","author":"Jazrawi, R.P.; De Caestecker, J.S.; Goggin, P.M.; Britten, A.J.; Joseph, A.E.A.; Maxwell, J.D.","year":"1993","unstructured":"Jazrawi RP, De Caestecker JS, Goggin PM, Britten AJ, Joseph AEA, Maxwell JD, et al. Kinetics of hepatic handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1993; 106: 134-42."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hep.1840120521","article-title":"Effect of chronic administration of endogenous bile acids in man","volume":"12","year":"1990","unstructured":"Marteau P, Chazouilleres 0, Myara A, Jian R, Rambaud J-C, Poupon R. Effect of chronic administration of endogenous bile acids in man. Hepatology 1990; 12: 1206-8.","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0016-5085(90)90834-N","article-title":"Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids","volume":"98","author":"Stiehl, A.; Raedsch, R.; Rudolph, G.","year":"1990","unstructured":"Stiehl A, Raedsch R, Rudolph G. Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. Gastroenterology 1990; 98: 424-8.","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian multicentre double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote, E.J.; Cauch-Dudek, K.; Walker, V.; Bailey, R.J.; Blendis, L.M.; Ghent, C.N.","year":"1994","unstructured":"Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, et al. The Canadian multicentre double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-56.","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840120308","article-title":"Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis","volume":"12","author":"Stiehl, A.; Rudolph, G.; Raedsch, R.; Moller, B.; Hoff, U.; Lotterer, E.","year":"1990","unstructured":"Stiehl A, Rudolph G, Raedsch R, Moller B, Hoff U, Lotterer E, et al. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1990; 12: 492-7.","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.1840170412","article-title":"Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"17","author":"Poupon, R.E.; Chretien, Y.; Poupon, Paumgartner; G.","year":"1993","unstructured":"Poupon RE, Chretien Y, Poupon, Paumgartner G. Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1993; 17: 599-604.","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/hep.1840140609","article-title":"Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration","volume":"14","author":"Crosignani, A.; Podda, M.; Battezzati, P.M.; Bertolini, E.; Zuin, M.; Watson, D.; Setchell, K.D.R.","year":"1991","unstructured":"Crosignani A, Podda M, Battezzati PM, Bertolini E, Zuin M, Watson D, Setchell KDR. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology 1991; 14: 1000-7.","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0022-2275(20)38207-9","article-title":"Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis","volume":"30","author":"Batta, A.K.; Arora, R.; Salen, G.; Tint, G.S.; Eskreis, D.; Katz, S.","year":"1989","unstructured":"Batta AK, Arora R, Salen G, Tint GS, Eskreis D, Katz S. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis. J Lipid Res 1989; 30: 1953-62.","journal-title":"J Lipid Res"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/BF01295917","article-title":"Ursodeoxycholic administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis","volume":"38","author":"Mazzella, G.; Parini, P.; Bazzoli, F.; Villanova, N.; Festi, D.; Aldini, R.","year":"1993","unstructured":"Mazzella G, Parini P, Bazzoli F, Villanova N, Festi D, Aldini R, et al. Ursodeoxycholic administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Dig Dis Sci 1993; 38: 896-902.","journal-title":"Dig Dis Sci"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease","volume":"15","author":"Beuers, U.; Spengler, U.; Zwiebel, F.M.; Pauletzki, J.; Fischer, S.; Paumgartner, G.","year":"1992","unstructured":"Beuers U, Spengler U, Zwiebel FM, Pauletzki J, Fischer S, Paumgartner G. Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology 1992; 15: 603-8.","journal-title":"Hepatology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.1840140527","article-title":"Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes","volume":"14","author":"Heuman, D.M.; Pandak, W.M.; Hylemon, P.H.; Vlahcevic, Z.R.","year":"1991","unstructured":"Heuman DM, Pandak WM, Hylemon PH, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991; 14: 920-6.","journal-title":"Hepatology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/hep.1840120307","article-title":"Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes","volume":"12","author":"Galle, P.R.; Theilmann, L.; Raedsch, R.; Otto, G.; Stiehl, A.","year":"1990","unstructured":"Galle PR, Theilmann L, Raedsch R, Otto G, Stiehl A. Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. Hepatology 1990; 12: 486-91.","journal-title":"Hepatology"},{"key":"ref_32","first-page":"471","article-title":"Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria","volume":"19","author":"Krahenbuhl, S.; Talos, C.; Fischer, S.; Reichen, J.","year":"1993","unstructured":"Krahenbuhl S, Talos C, Fischer S, Reichen J. Toxicity of bile acids on the electron transport chain of isolated rat liver mitochondria. Hepatology 1993; 19: 471-9.","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/00042737-199412000-00016","article-title":"Effects of bile acids on human hepatic mitochondria","volume":"6","author":"Lim, A.G.; Ahmed, H.A.; Jazrawi, R.P.; Northfield, T.C.","year":"1994","unstructured":"Lim AG, Ahmed HA, Jazrawi RP, Northfield TC. Effects of bile acids on human hepatic mitochondria. Eur Jf Gastroenterol Hepatol 1994; 6: 1157-63.","journal-title":"Eur Jf Gastroenterol Hepatol"},{"key":"ref_34","first-page":"156","article-title":"Mitochondrial toxicity and partial reversal by ursodeoxycholate","volume":"16","author":"Krahenbuhl, S.; Talos, C.; Reichen, J.","year":"1992","unstructured":"Krahenbuhl S, Talos C, Reichen J. Mitochondrial toxicity and partial reversal by ursodeoxycholate. Hepatology 1992; 16: 156.","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/0016-5085(93)90672-Y","article-title":"Hepatoprotective properties of ursodeoxycholic acid","volume":"104","author":"Heuman, D.","year":"1993","unstructured":"Heuman D. Hepatoprotective properties of ursodeoxycholic acid. GastroenterologAy 1993; 104: 1865-70.","journal-title":"GastroenterologAy"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0016-5085(94)90027-2","article-title":"Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts","volume":"106","author":"Heuman, D.M.; Bajaj, R.","year":"1994","unstructured":"Heuman DM, Bajaj R. Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. Gastroenterology 1994; 106: 1333-41.","journal-title":"Gastroenterology"},{"key":"ref_37","first-page":"45","article-title":"The effect of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocyte and erythrocyte membranes, gut","volume":"34","author":"Lim, A.G.; Ahmed, H.A.; Jazrawi, R.P.; Northfield, T.C.","year":"1993","unstructured":"Lim AG, Ahmed HA, Jazrawi RP, Northfield TC. The effect of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocyte and erythrocyte membranes, gut 1993; 34: S45."},{"key":"ref_38","first-page":"1736","article-title":"Guldutuna 5, Zimmer G, Imhof M, Bhatti 5, Tiangeng Y, Leuschner U. Molecular aspects of membrane stabilisation by ursodeoxycholate","volume":"104","year":"1993","unstructured":"Guldutuna 5, Zimmer G, Imhof M, Bhatti 5, Tiangeng Y, Leuschner U. Molecular aspects of membrane stabilisation by ursodeoxycholate. Hepatology 1993; 104: 1736-44.","journal-title":"Hepatology"},{"key":"ref_39","first-page":"1725","article-title":"Influence of ursodeoxycholic acid on biochemical parameters in cholestatic liver disease","volume":"90","author":"Fisher, M.M.; Paradine, M.E.","year":"1986","unstructured":"Fisher MM, Paradine ME. Influence of ursodeoxycholic acid on biochemical parameters in cholestatic liver disease. Gastroenterotogry 1986; 90: 1725.","journal-title":"Gastroenterotogry"},{"issue":"175","key":"ref_40","first-page":"103","article-title":"et at. A randomized, double blind, placebo controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis","volume":"18","author":"Combes, B.; Carithers, R.L.; Maddrey, W.C.; Munoz, S.J.; Mcdonald, M.F.; Garcia-Tsao, G.","year":"1993","unstructured":"Combes B, Carithers RL, Maddrey WC, Munoz SJ, Mcdonald MF, Garcia-Tsao G, et at. A randomized, double blind, placebo controlled trial of ursodeoxycholic acid (UDCA) in primary biliary cirrhosis. Hepaotolgy 1993; 18: 175A. 41 Ludwig J, Dickson ER, McDonald GSA. Staging of non-suppurrative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A 1978; 379: 103-12.","journal-title":"Hepaotolgy; Staging of non-suppurrative destructive cholangitis (syndrome of primary biliary cirrhosis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: a model of decision making","volume":"10","author":"Dickson, E.R.; Grambsch, P.M.; Fleming, T.R.; Fisher, L.D.; Langworthy, A.","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A. Prognosis in primary biliary cirrhosis: a model of decision making. Hepatology 1989; 10: 1-7.","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro, J.M.; Smith, H.; Schaffner, F.","year":"1979","unstructured":"Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 137-40.","journal-title":"Gut"},{"key":"ref_43","first-page":"424","article-title":"Diseases of the intrahepatic bile ducts","volume-title":"Pathology of the liver","author":"Portmann, B.; Macsween, R.N.M.","year":"1987","unstructured":"Portmann B, Macsween RNM. Diseases of the intrahepatic bile ducts. In: Macsween RNM, Anthony P, Scheuer P, eds. Pathology of the liver. 2nd ed. London: Churchill Livingstone, 1987: 424-53.","edition":"2nd ed"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/0016-5085(95)28629-2","article-title":"Combined analysis of French, American and Canadian randomised controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis","volume":"108","author":"Heathcote, E.J.; Lindor, K.D.; Poupon, R.; Cauch-Dudek, K.; Dickson, E.R.; Trout, R.","year":"1995","unstructured":"Heathcote EJ, Lindor KD, Poupon R, Cauch-Dudek K, Dickson ER, Trout R, et al. Combined analysis of French, American and Canadian randomised controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis. Gastroenterology 1995; 108: A1082.","journal-title":"Gastroenterology"},{"issue":"192","key":"ref_45","first-page":"47","article-title":"Ursodeoxycholic acid does not cure primary biliary cirrhosis but prolongs survival. Results of a 3-11 years'","volume":"116","author":"Leuschner, U.; Guldutuna, S.; Imhof, M.; Leuschner, M.","year":"1992","unstructured":"Leuschner U, Guldutuna S, Imhof M, Leuschner M. Ursodeoxycholic acid does not cure primary biliary cirrhosis but prolongs survival. Results of a 3-11 years' study. Hepatology 1992; 116: 192A. 47 Bateson MC, Gedling P. Effect of ursodeoxycholic acid on survival in primary biliary cirrhosis. Gut 1994; 35: S20.","journal-title":"study. Hepatology; Effect of ursodeoxycholic acid on survival in primary biliary cirrhosis"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"and the UDCA study group. Ursodiol for the longterm treatment of primary biliary cirrhosis","volume":"330","author":"Poupon, R.E.; Poupon, R.; Balkau, B.","year":"1994","unstructured":"Poupon RE, Poupon R, Balkau B, and the UDCA study group. Ursodiol for the longterm treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-7.","journal-title":"N Engl J Med"},{"key":"ref_47","first-page":"834","article-title":"Ursodeoxycholic acid improves hepatic excretion in primary biliary cirrhosis","volume":"i:","author":"Lim, A.G.; Jazrawi, R.P.; Maxwell, J.D.; Northfield, T.C.","year":"1994","unstructured":"Lim AG, Jazrawi RP, Maxwell JD, Northfield TC. Ursodeoxycholic acid improves hepatic excretion in primary biliary cirrhosis. Gut 1994; 35: SlI. 50 Poupon R, Chretien Y, Ballet F, Calmus Y, Damis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis. Lancet 1987; i: 834-6.","journal-title":"Gut; 35: SlI. 50 Poupon R, Chretien Y, Ballet F, Calmus Y, Damis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0168-8278(90)90134-D","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III","volume":"10","author":"Lotterer, E.; Stiehl, A.; Raedsch, R.; Foelsch, U.R.; Bircher, R.","year":"1990","unstructured":"Lotterer E, Stiehl A, Raedsch R, Foelsch UR, Bircher R. Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III. J Hepatol 1990; 10: 284-90.","journal-title":"J Hepatol"},{"issue":"1992","key":"ref_49","series-title":"Proceedings of the XIIth International Bile Acid Meeting. Basel, Switzerland: Falk Symposium","article-title":"Effects of ursodeoxycholic acid on hepatic function and portal hypertension in primary biliary cirrhosis","volume":"68","author":"Huet, P.M.; Willems, B.; Huet, J.; Poupon, R.","unstructured":"Huet PM, Willems B, Huet J, Poupon R. Effects of ursodeoxycholic acid on hepatic function and portal hypertension in primary biliary cirrhosis. In: Proceedings of the XIIth International Bile Acid Meeting. Basel, Switzerland: Falk Symposium no 68, 1992: 118."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02090053","article-title":"Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease","volume":"39","author":"Floreani, A.; Zappala, F.; Mazzetto, M.; Naccarato, R.; Plebani, M.; Charamonte, M.","year":"1994","unstructured":"Floreani A, Zappala F, Mazzetto M, Naccarato R, Plebani M, Charamonte M. Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Dig Dis Sci 1994; 39: 9-14.","journal-title":"Dig Dis Sci"},{"key":"ref_51","series-title":"Proceedings of the XIIth International Bile Acid Meeting. Basle, Switzerland: Falk Symposium","first-page":"50","article-title":"Italian Multicentre Group for the Study of UDCA in PBC. Long term effects of the administration of ursodeoxycholic acid alone or with colchicine in patients with primary biliary cirrhosis. A double blind multicentre trial","volume":"68","author":"Podda, M.","year":"1992","unstructured":"Podda M, Italian Multicentre Group for the Study of UDCA in PBC. Long term effects of the administration of ursodeoxycholic acid alone or with colchicine in patients with primary biliary cirrhosis. A double blind multicentre trial. In: Proceedings of the XIIth International Bile Acid Meeting. Basle, Switzerland: Falk Symposium no 68, 1992: 50-1."},{"key":"ref_52","series-title":"Proceedings of the XIIth International Bile Acid Meeting. Basle, Switzerland: Falk Symposium","first-page":"48","article-title":"Combined urso plus colchicine treatment in primary biliary cirrhosis: efficacy, pharmacology and urso - colchicine drug interactions","volume":"68","author":"Raedsch, R.; Stiehl, A.; Rudi, J.; Schlenker, T.; Gerteis, C.; Kommerell, B.; Sherrmann, J.M.","year":"1992","unstructured":"Raedsch R, Stiehl A, Rudi J, Schlenker T, Gerteis C, Kommerell B, Sherrmann JM. Combined urso plus colchicine treatment in primary biliary cirrhosis: efficacy, pharmacology and urso - colchicine drug interactions. In: Proceedings of the XIIth International Bile Acid Meeting. Basle, Switzerland: Falk Symposium no 68, 1992: 48-9."},{"key":"ref_53","first-page":"84","article-title":"The therapeutic effects of ursodiol and methotrexate are additive and well tolerated in primary biliary cirrhosis. Hepatology 1992; 16: 92A. 57 Wolfhagen FHJ, van Buuren HR, Schalm SW. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis","volume":"44","author":"Kaplan, M.M.","year":"1994","unstructured":"Kaplan MM. The therapeutic effects of ursodiol and methotrexate are additive and well tolerated in primary biliary cirrhosis. Hepatology 1992; 16: 92A. 57 Wolfhagen FHJ, van Buuren HR, Schalm SW. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med 1994; 44: 84-90.","journal-title":"Neth J Med"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM199405123301912","article-title":"Primary biliary cirrhosis - a first step in prolonging survival","volume":"330","author":"Kaplan, M.M.","year":"1994","unstructured":"Kaplan MM. Primary biliary cirrhosis - a first step in prolonging survival. N EnglJ Med 1994; 330: 1386-7.","journal-title":"N EnglJ Med"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(94)92029-X","article-title":"Leucocyte-endothelial interactions and regulation of leucocyte migration","volume":"343","author":"Adams, D.H.; Shaw, S.","year":"1994","unstructured":"Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994; 343: 831-6.","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.1840140305","article-title":"Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"14","author":"Adams, D.H.; Hubscher, S.G.; Shaw, J.","year":"1991","unstructured":"Adams DH, Hubscher SG, Shaw J, et al. Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14: 426-31.","journal-title":"Hepatology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/hep.1840200416","article-title":"Soluble intercellular adhesion molecule 1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis","volume":"20","author":"Lim, A.G.; Jazrawi, R.P.; Levy, J.H.; Douds, A.C.; Zuin, M.; Maxwell, J.D.; Northfield, T.C.","year":"1994","unstructured":"Lim AG, Jazrawi RP, Levy JH, Douds AC, Zuin M, Maxwell JD, Northfield TC. Soluble intercellular adhesion molecule 1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology 1994; 20: 882-8.","journal-title":"Hepatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0168-8278(95)80104-9","article-title":"Soluble E-selectin and vascular cell adhesion molecule-i (VCAM-1) in primary biliary cirrhosis","volume":"22","author":"Lim, A.G.; Jazrawi, R.P.; Levy, J.H.; Petroni, M.L.; Douds, A.C.; Maxwell, J.D.; Northfield, T.C.","year":"1995","unstructured":"Lim AG, Jazrawi RP, Levy JH, Petroni ML, Douds AC, Maxwell JD, Northfield TC. Soluble E-selectin and vascular cell adhesion molecule-i (VCAM-1) in primary biliary cirrhosis. J Hepatol 1995; 22: 416-22.","journal-title":"J Hepatol"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(94)93055-4","article-title":"Soluble forms of ICAM-1 in insulin dependent diabetes mellitus","volume":"343","author":"de Vries RPP; H, Kolb; S, Martin","year":"1994","unstructured":"de Vries RPP, Kolb H, Martin S. Soluble forms of ICAM-1 in insulin dependent diabetes mellitus. Lancet 1994; 343: 1590-92.","journal-title":"Lancet"},{"key":"ref_60","first-page":"8564","article-title":"Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis","volume":"85","author":"Fussey, S.P.; Guet, JR, James; OF, Bassendine; MF, Yeaman; S.J.","year":"1988","unstructured":"Fussey SP, Guet JR, James OF, Bassendine MF, Yeaman SJ. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Nad Acad Sci USA 1988; 85: 8564-8.","journal-title":"Proc Nad Acad Sci USA"},{"key":"ref_61","first-page":"912","article-title":"T-cell responses to human pyruvate dehydrogenase complex and its components in primary biliary cirrhosis","volume":"106","author":"Jones, D.E.J.; Palmer, J.M.; Yeaman, S.J.; Diamond, A.G.; Bassendine, M.F.","year":"1994","unstructured":"Jones DEJ, Palmer JM, Yeaman SJ, Diamond AG, Bassendine MF. T-cell responses to human pyruvate dehydrogenase complex and its components in primary biliary cirrhosis. Gastroenterology 1994; 106: A912.","journal-title":"Gastroenterology"},{"key":"ref_62","first-page":"2653","article-title":"Molecular mimicry in primary biliary cirrhosis","volume":"91","author":"de Water J, Van; J, Turchany; PC, Leung; J, Lake; S, Munoz; CD, Surh","year":"1993","unstructured":"Van de Water J, Turchany J, Leung PC, Lake J, Munoz S, Surh CD, et al. Molecular mimicry in primary biliary cirrhosis. J Clin Invest 1993; 91: 2653-64.","journal-title":"J Clin Invest"},{"key":"ref_63","first-page":"1031","article-title":"Abnormal expression of the E component of the pyruvate dehydrogenase complex on the lumina2l surface of biliary epithelium occurs before major histocompatibilit? complex class II and BB1\/B7 expression","volume":"21","author":"Tsuneyama, K.; Van de Water, J.; Leung, P.S.C.; Sanghoon, C.; Nakanuma, Y.; Kaplan, M.","year":"1995","unstructured":"Tsuneyama K, Van de Water J, Leung PSC, Sanghoon C, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E component of the pyruvate dehydrogenase complex on the lumina2l surface of biliary epithelium occurs before major histocompatibilit? complex class II and BB1\/B7 expression. Hepatology 1995; 21: 1031-7.","journal-title":"Hepatology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.37.3.301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:51:49Z","timestamp":1765644709000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.37.3.301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":63,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1995,9,1]]},"published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1136\/gut.37.3.301"],"URL":"https:\/\/doi.org\/10.1136\/gut.37.3.301","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}